Pharmaceutical

South Africa Leads Transformation of African Healthcare Supply Chains
Management & Administration South Africa Leads Transformation of African Healthcare Supply Chains

Establishing health sovereignty across Africa requires a shift from international import reliance toward a self-sustaining ecosystem anchored by regional manufacturing hubs. For decades, the continent remained vulnerable to global supply shocks, frequently finding itself at the end of the queue for

Louisiana Surgeon General Challenges Public Health Norms
Clinical & Pharma Louisiana Surgeon General Challenges Public Health Norms

In the humid halls of the Louisiana State Capitol, a radical ideological shift is currently unfolding as the state’s top medical official attempts to rewrite the foundational principles of community wellness through a lens of absolute individual autonomy. The traditional pillars of public

Can AFT Pharmaceuticals Sustain Its Rapid Global Growth?
Clinical & Pharma Can AFT Pharmaceuticals Sustain Its Rapid Global Growth?

The company's net debt jumped from NZD 14.5 million to NZD 38.6 million as it aggressively funded its expansion into South Africa and other global regions. Despite the rising debt levels, the 2026 fiscal year proved to be a landmark period for AFT Pharmaceuticals as it effectively balanced capital

New Reforms Target Barriers to Clinical Trial Participation
Clinical & Pharma New Reforms Target Barriers to Clinical Trial Participation

The profound disconnect between the cutting-edge medical research happening in sterile laboratories and the everyday reality of patients waiting for life-saving treatments remains one of the most significant challenges in modern healthcare. While the scientific community continues to unlock the

How Is Research Redefining the Breast Cancer Fight?
Clinical & Pharma How Is Research Redefining the Breast Cancer Fight?

Peer-reviewed scientific developments act as the primary defense against medical misinformation, providing patients with evidence-based guidelines for managing their health. While the month of October is widely recognized for its vibrant pink ribbons and awareness campaigns, August 18 marks a more

How Is the IRA Reshaping Payer Strategy and Patient Access?
Management & Administration How Is the IRA Reshaping Payer Strategy and Patient Access?

The redesign of the Medicare Part D benefit aims to cap out-of-pocket spending but simultaneously shifts significant financial liabilities onto private payers. This regulatory pivot represents one of the most substantial transformations in the pharmaceutical landscape since the inception of the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later